We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The deadline for the Brazilian government's threat to break patents on an HIV/AIDS
drug used in the country's treatment programme is due to expire today.
A French pharmaceutical association has claimed that the sector is a leading
driver of the country's tortuous health reform process. According to manufacturers
group LEEM, drugmakers have been responsible for savings of around EUR550mn
(US$595.65mn) in 2005 alone.
India's Science and Technology Ministry has requested that the US authorities
consider accepting clinical research data generated in India for US FDA drug
approvals.
Sumitomo Pharmaceuticals and Merck & Co., today announced that they have
signed an agreement to collaborate on SM13496 (lurasidone), an atypical antipsychotic
compound currently in Phase II development for the treatment of schizophrenia,
one of the most chronic and disabling of the severe mental illnesses.
Millipore today announced it has completed the acquisition of MicroSafe, B.V.,
for approximately $9.3M. MicroSafe is a contract laboratory that develops assays
and provides a range of testing services to help leading European biotech and
pharmaceutical customers monitor for quality and compliance in the drug manufacturing
process.
Purdue Pharma is laying off 825 employees, or 38 percent of its work force,
after losing a patent case that paves the way for sales of a generic version
of its powerful painkiller OxyContin, company officials said Friday.
Ugandan government officials have hurried to soothe mounting concerns over alleged
corruption involving transfers from the UN-administered Global Fund.